TransCode Therapeutics Inc (NASDAQ:RNAZ) currently has a daily average trading volume of 1.70M but it saw 4573711 shares traded in last market. With a market cap of 10.62M USD, the company’s current market price of $0.62 came falling about -5.15 while comparing to the previous closing price of $0.65. In past 52 weeks, the stock remained buoying in the range of price level as high as $38.00 and as low as $0.22. In the recent trading on the day, stock has struck highest price mark of $0.5633 while lowest mark touched by it was $0.73.
Taking a look at 20-day trading activity of TransCode Therapeutics Inc (RNAZ) gives us an average price of $0.3226, while its current price level is -98.38% below from 52-week high level whereas it is 184.81% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.3261 while that of 200 days or SMA-200 reads an average of $1.3761. A closer look into the stock’s movement over the week reveals that its volatility is standing at 35.32% during that period while stretching the period over a month that decreases to 19.60%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 73.24 which implies that the stock is in overbought territory.
Over the week, RNAZ’s stock price is moving 62.75% up while it is 122.90% when we observe its performance for the past one month. Year-to-date it is -90.67% down and over the past year, the stock is showing a downside performance of -97.77%.
Currently, TransCode Therapeutics Inc’s total number of outstanding shares is 17.27M. Company’s return on investment (ROI) stands at -1354.12% and return on equity (ROE) at -1048.70%. Stock’s beta reads 0.55. Stock has a price to book (P/B) ratio of 3.38. Its return on asset (ROA) is -334.48% on average.
